CervoMed Inc.
CRVO
$2.89
-$0.02-0.69%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 8.70K | 322.60K | 1.76M | 1.92M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 8.70K | 322.60K | 1.76M | 1.92M |
| Cost of Revenue | 5.01M | 5.83M | 6.04M | 5.11M | 4.71M |
| Gross Profit | -5.01M | -5.82M | -5.72M | -3.35M | -2.80M |
| SG&A Expenses | 2.98M | 2.51M | 2.33M | 3.27M | 2.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.11M | 8.34M | 8.37M | 8.37M | 7.22M |
| Operating Income | -8.11M | -8.33M | -8.04M | -6.62M | -5.30M |
| Income Before Tax | -7.96M | -8.09M | -7.73M | -6.26M | -4.89M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.96M | -8.09M | -7.73M | -6.26M | -4.89M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.96M | -8.09M | -7.73M | -6.26M | -4.89M |
| EBIT | -8.11M | -8.33M | -8.04M | -6.62M | -5.30M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.86 | -0.87 | -0.84 | -0.70 | -0.56 |
| Normalized Basic EPS | -0.54 | -0.55 | -0.52 | -0.44 | -0.35 |
| EPS Diluted | -0.86 | -0.87 | -0.84 | -0.70 | -0.56 |
| Normalized Diluted EPS | -0.54 | -0.55 | -0.52 | -0.44 | -0.35 |
| Average Basic Shares Outstanding | 9.26M | 9.26M | 9.25M | 8.95M | 8.70M |
| Average Diluted Shares Outstanding | 9.26M | 9.26M | 9.25M | 8.95M | 8.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |